GoHealthcare AI Governance Center
Artificial Intelligence Procurement
Vendor Evaluation, Diligence, Contract Terms, and Renewal Discipline for Musculoskeletal Specialty Organizations
What is healthcare artificial intelligence procurement governance?
Procurement is the point of maximum leverage in artificial intelligence governance. Every term the organization fails to obtain before signature becomes a control it cannot exercise for the life of the agreement, and most of the governance failures described elsewhere in this Center trace back to a contract that did not require what the organization later needed: notice of model changes, disclosure of performance characteristics, clarity on training data, a statement of where processing occurs, audit rights, and a clean exit.
Document Control
Publication and Review Detail
| Document Control | Detail |
|---|---|
| Document Identifier | GH-MSK-AI-007 |
| Version | 1.0 |
| Effective Date | August 6, 2026 |
| Publication Series | GoHealthcare MSK Specialty Procedure Library -- AI Governance Center |
| Standard Applied | GoHealthcare Clinical Procedure Guide Standard v1.0 |
| Developed By | GoHealthcare Practice Solutions under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions |
| Credentials | MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare AI Governance |
| Scope of Review | Vendor diligence practice, contracting requirements, privacy and security obligations, device and certification requirements, and musculoskeletal specialty operations |
| Primary Audience | Practice administrators, contracting and finance leadership, compliance and privacy officers, information technology leadership, counsel, and executives |
| Document Type | Educational and operational reference |
01
GoHealthcare AI Governance Center
Why is procurement the point of maximum leverage in healthcare AI governance?
Original section: Overview
Musculoskeletal specialty organizations face a specific structural disadvantage here. Most artificial intelligence does not arrive through a procurement process at all. It arrives as a feature inside a practice management system, clearinghouse, transcription service, patient engagement platform, or imaging partner, enabled by a toggle, governed by terms incorporated by reference into an agreement signed years earlier. The first procurement discipline is therefore not negotiation. It is detection.
This page covers detection of embedded artificial intelligence, the diligence questions that matter, the contract terms GoHealthcare treats as non-negotiable and those that are negotiable, the practical realities of negotiating leverage for a specialty practice, and renewal discipline. It addresses procurement of artificial intelligence capability, not general vendor management, which the organization should already have.
Risk tiering, which determines how much diligence is proportionate, is covered in AI Risk Management, identifier GH-MSK-AI-004. Readiness assessment, which should occur before contract signature rather than before go-live, is covered in AI Readiness, identifier GH-MSK-AI-002.
Back to page navigation02
GoHealthcare AI Governance Center
What should healthcare leaders know about AI procurement at a glance?
Original section: AI Procurement at a Glance
The procurement position for an administrator or contracting lead acquiring artificial intelligence capability.
| Element | Position and Operational Requirement |
|---|---|
| Where most artificial intelligence actually enters the organization | As an embedded feature in an existing product, enabled by an administrative toggle, under terms incorporated by reference into an agreement predating the feature. Not through procurement. |
| First procurement control | Restrict who may enable vendor artificial intelligence features. This is the highest-leverage single control in the entire program and costs nothing. |
| Diligence proportionate to tier | Tier 1 requires a business associate agreement check and a disclosure questionnaire. Tier 3 requires full diligence including performance evidence, input variables, training data position, change management, and audit rights. |
| Non-negotiable terms | Business associate agreement covering the artificial intelligence processing; written notice of material model changes; a stated position on training data use; disclosure of processing location; data return and deletion at termination; and no term that would prevent the organization from meeting a legally required human determination. |
| Highly desirable terms | Performance characteristic disclosure, input variable disclosure, audit rights, service level commitments, indemnification for artificial intelligence output, and notice of adverse regulatory action. |
| The term most often missing | Written notice of material model changes. Its absence means prior validation can be invalidated silently and the organization has no signal. |
| The question vendors most often cannot answer | What input variables the model uses. Record the inability as a material diligence finding rather than proceeding as though the question was answered. |
| Negotiating leverage | Lowest at mid-term, highest at renewal and at initial purchase. Time the artificial intelligence terms conversation to renewal wherever possible. |
| Device status | Where the tool may meet the definition of a device, confirm clearance status, intended use, and any predetermined change control plan, and confirm that the organization's intended use falls within the cleared indication. |
| Renewal discipline | No tier 3 renewal without current monitoring data, a revalidation within the period, and confirmation that the artificial intelligence terms remain adequate. |
03
GoHealthcare AI Governance Center
Which laws, regulations, and standards shape healthcare AI procurement?
Original section: Regulatory and Standards Anchors for Procurement
The authorities below are the ones that bear most directly on this domain. They were verified against primary sources during preparation of this document. Artificial intelligence requirements change frequently, and several items are subject to active litigation or pending amendment. Verify current status before acting. The full cross-domain baseline appears in the AI Governance Center hub page, identifier GH-MSK-AI-000.
| Authority or Instrument | Operational Effect on This Domain |
|---|---|
| Health Insurance Portability and Accountability Act and the Health Information Technology for Economic and Clinical Health Act | A vendor that creates, receives, maintains, or transmits protected health information on the organization's behalf is a business associate. The agreement must cover the artificial intelligence processing specifically, including any use of the organization's data beyond providing the service, and must address subcontractors and model providers in the chain. |
| Texas Senate Bill 1188 and Health and Safety Code provisions | Restrict physical offshoring of electronic medical records. Procurement must therefore establish and document where vendor processing occurs, including processing performed by any subcontracted model provider. |
| HTI-1 decision support intervention criterion, 45 CFR 170.315(b)(11) | Certified health information technology must surface source attributes and developers must engage in intervention risk management for predictive decision support interventions. Where a vendor's product is or interfaces with certified health information technology, procurement should require delivery of this information rather than treating it as unavailable. |
| Section 1557 nondiscrimination rule, 45 CFR 92.210 | Reasonable efforts to identify tools using protected characteristics as input variables require the organization to be able to obtain that information. Procurement is where the right to obtain it is secured. Confirm current enforcement posture with counsel. |
| Food and Drug Administration device requirements | Where a tool meets the definition of a device, clearance status, intended use, and any predetermined change control plan are procurement diligence items. A predetermined change control plan means the vendor may modify the model within a pre-authorized scope, which the organization should understand before signing. |
| Medicare Advantage and state utilization review requirements | No contract term, service configuration, or workflow default may prevent the organization from meeting a legally required human determination. This is a categorical procurement constraint. |
| Joint Commission Responsible Use of AI in Healthcare certification | Effective data management and transparency expectations are discharged substantially through what the organization secured contractually. Procurement is where certification readiness is largely determined. |
04
GoHealthcare AI Governance Center
How can healthcare organizations detect AI that bypassed procurement?
Original section: Detection: Artificial Intelligence That Never Went Through Procurement
Before improving procurement, close the path that bypasses it. In GoHealthcare's experience the majority of artificial intelligence in a specialty organization arrived without a procurement decision.
| Entry Path | Control |
|---|---|
| Vendor feature enabled by an administrative toggle | Restrict administrative rights to enable artificial intelligence features to named individuals, and route activation through the governance body. Highest leverage control available and free. |
| Vendor feature enabled by default in an update | Require written advance notice of new artificial intelligence features and of default-enabled changes. Where the contract does not require it, add the recurring vendor questionnaire as the detection mechanism. |
| Terms incorporated by reference into a pre-existing agreement | Review incorporated terms at each renewal. Many artificial intelligence terms sit in an online terms document the vendor may amend unilaterally, which is itself a diligence finding. |
| Free or low-cost tools adopted by a department | Procurement policy must apply below the dollar threshold that ordinarily triggers review, because artificial intelligence risk does not scale with price. |
| Consumer tools adopted by individual staff | Sanctioned enterprise alternative plus an acceptable use standard. Prohibition alone drives the behavior underground. |
| Capability arriving through a referral partner, imaging partner, or health information exchange | Data sharing and participation agreements should address what analytics are performed on the organization's data and by whom. |
The Recurring Vendor Questionnaire
Send a short written artificial intelligence disclosure questionnaire to every technology vendor at onboarding and then on a recurring cadence, at minimum annually and at each renewal.
Ask directly: does the product contain predictive or generative components; are any enabled by default; were any enabled for us and when; is our data used to train models; where does processing occur; and will you notify us in writing of material model changes.
Retain the answers. In GoHealthcare's experience this single practice doubles the known inventory on the first pass and continues to surface additions on every subsequent cycle.
Back to page navigation05
GoHealthcare AI Governance Center
How should AI vendor diligence change by risk tier?
Original section: Diligence Proportionate to Tier
| Diligence Item | Tier 1 | Tier 2 | Tier 3 |
|---|---|---|---|
| Artificial intelligence disclosure questionnaire completed | Required | Required | Required |
| Business associate agreement covering the artificial intelligence processing | Required where protected health information is involved | Required | Required |
| Processing location established in writing | Required | Required | Required |
| Training data position established in writing | Required | Required | Required |
| Vendor security assessment under the existing vendor risk process | Light | Standard | Standard |
| Performance evidence in a comparable population | Not required | Requested | Required |
| Input variables disclosed | Not required | Requested | Required, and inability recorded as a material finding |
| Source attributes where certified health information technology is involved | Not required | Requested | Required |
| Device clearance status and intended use | Where applicable | Where applicable | Required where applicable |
| Model change management and notice commitment | Requested | Required | Required in writing |
| Reference checks with comparable specialty organizations | Not required | Recommended | Required |
| Local validation plan agreed before signature | Not required | Recommended | Required |
| Audit rights | Not required | Requested | Required |
| Exit, data return, and deletion terms | Required | Required | Required with a defined transition period |
06
GoHealthcare AI Governance Center
Contract Terms
Non-Negotiable
GoHealthcare treats the following as conditions of doing business. Where a vendor will not agree, that is a decision to escalate to the governance body and counsel rather than a term to concede quietly.
- A business associate agreement that expressly covers the artificial intelligence processing, names the permitted uses of protected health information, and flows down to subcontractors and any third-party model provider in the chain.
- Written notice of material changes to the model, with a defined notice period. Without this, prior validation can be invalidated silently.
- A clear written statement of whether the organization's data is used to train, tune, or improve the vendor's models, and where it is, an opt-out or an express permission negotiated on the organization's
terms.
- Written disclosure of where processing physically occurs, including processing by subcontractors, given the direct state law constraint on offshoring electronic medical records.
- Data return in a usable format and certified deletion at termination, with a defined transition period.
- No term, configuration default, or service design that would prevent the organization from meeting a legally required human determination or from exercising clinical primacy.
- The right to suspend use immediately without penalty where the organization identifies a safety, privacy, or compliance concern.
Highly Desirable and Usually Obtainable
- Disclosure of performance characteristics, including how performance was measured, in what population, and against what standard.
- Disclosure of input variables, or at minimum of whether protected characteristics or close proxies are used.
- Delivery of source attributes where the product is or interfaces with certified health information technology.
- Audit rights, including the right to sample outputs and to receive reasonable cooperation in an investigation.
- Service level commitments including availability, support response, and defect remediation timeframes.
- Notice of adverse regulatory action, safety communication, or material litigation concerning the product.
- Indemnification addressing claims arising from the artificial intelligence output, coordinated with the organization's insurance position.
- Price protection at renewal, particularly where the organization will have built workflow dependency.
- Advance notice of new artificial intelligence features and of any feature that will be enabled by default.
Terms to Scrutinize
| Term | Why It Matters |
|---|---|
| Unilateral amendment of incorporated online terms | Allows the vendor to change artificial intelligence terms without negotiation. Seek notice and a right to terminate on material change. |
| Broad license to use organizational data for product improvement | Frequently drafted broadly enough to cover model training. Read it specifically against the training data question rather than assuming the business associate agreement resolves it. |
| Limitation of liability excluding artificial intelligence output | Shifts the entire risk of the output to the organization while the vendor controls the model. |
| Vendor discretion to define material change | Renders a change notice commitment unenforceable in practice. Define material by reference to objective criteria where possible. |
| Automatic renewal with short notice windows | Eliminates the renewal leverage that is the organization's principal opportunity to obtain artificial intelligence terms. |
| Data deletion at termination subject to vendor backup policy | Frequently means data persists indefinitely. Seek certified deletion with a defined timeframe. |
| Restrictions on publishing performance results | May limit the organization's ability to report a safety concern or to participate in professional discourse. Scrutinize scope. |
07
GoHealthcare AI Governance Center
Negotiating Leverage in a Specialty Practice
Specialty practices routinely conclude that they lack leverage with large vendors. That is partly true and frequently overstated. The following approaches are what GoHealthcare has seen work.
- Time the conversation to renewal. Leverage at mid-term is near zero and at renewal is substantial. Calendar the artificial intelligence terms conversation ninety days before the notice window opens.
- Ask in writing and retain the answer. Vendors frequently provide information they will not contractually commit to, and a written answer is useful diligence evidence even without a contract term.
- Separate the terms that require negotiation from those that require only disclosure. Many organizations spend leverage on disclosure items the vendor would have provided on request.
- Use a standard artificial intelligence addendum rather than negotiating term by term. A short, reasonable, consistently presented addendum is accepted far more often than ad hoc redlines.
- Aggregate where possible. Independent practice associations, management services organizations, and group purchasing arrangements produce materially better artificial intelligence terms than individual practices.
- Be willing to record a refusal. A vendor that will not commit to notice of material model changes has told the organization something important, and the refusal belongs in the risk assessment and the governance decision log.
- Do not concede the categorical constraints. Terms that would prevent a legally required human determination are not negotiable regardless of leverage.
08
GoHealthcare AI Governance Center
Renewal Discipline
Renewal is the only recurring point at which an organization has leverage, and it is routinely allowed to pass automatically. GoHealthcare recommends treating tier 3 renewal as a governance decision rather than a finance one.
- Current monitoring data for the system has been reviewed, including override rate, audit agreement, and the downstream outcome measure.
- A revalidation has occurred within the current term, or is scheduled before renewal takes effect.
- Any incidents during the term have been reviewed and closed.
- The recurring artificial intelligence disclosure questionnaire has been completed for the current period.
- Incorporated online terms have been re-reviewed for unilateral changes made during the term.
- The training data position and processing location have been re-confirmed, because both change.
- Terms that were not obtained at initial contracting have been re-raised.
- The business case has been re-tested against actual measured benefit rather than the original projection.
- Alternatives have been surveyed, at least briefly, so that the renewal is an informed decision.
- The renewal decision is recorded in the governance decision log.
09
GoHealthcare AI Governance Center
Artificial Intelligence Procurement Checklist
Apply proportionate to tier. Tier 1 acquisitions require only the detection and baseline groups.
Detection and Baseline
- Administrative rights to enable vendor artificial intelligence features are restricted to named individuals.
- The artificial intelligence disclosure questionnaire has been completed by the vendor in writing and retained.
- The product's artificial intelligence components have been identified, including components enabled by default.
- A business associate agreement covers the artificial intelligence processing where protected health information is involved.
- The training data position has been established in writing.
- The processing location has been established in writing, including subcontractor processing.
- The acquisition has been presented to the governance body and tiered.
Tier 3 Diligence
- Performance evidence has been provided, with the measurement method, population, and comparison standard described.
- Input variables have been disclosed, or the inability has been recorded as a material finding.
- Source attributes have been provided where certified health information technology is involved.
- Device clearance status and intended use have been confirmed where applicable, and the intended organizational use falls within the cleared indication.
- Model change management practice and notice commitment have been obtained in writing.
- Reference checks have been completed with comparable specialty organizations.
- A local validation plan has been agreed before signature.
- Readiness assessment has been completed before signature, not before go-live.
Contract Terms
- Business associate agreement covers artificial intelligence processing and flows down to subcontractors and model providers.
- Written notice of material model changes with a defined period.
- Training data use is expressly addressed with an opt-out or negotiated permission.
- Processing location is disclosed and change requires notice.
- Data return in usable format and certified deletion at termination with a transition period.
- No term prevents a legally required human determination or clinical primacy.
- Immediate suspension right without penalty on a safety, privacy, or compliance concern.
- Audit rights have been sought.
- Indemnification for artificial intelligence output has been sought and coordinated with the insurance position.
- Unilateral amendment of incorporated terms has been scrutinized and addressed.
- Automatic renewal and notice windows have been reviewed and calendared.
- Counsel has reviewed the artificial intelligence terms.
Renewal
- The artificial intelligence terms conversation is calendared ninety days before the notice window.
- Current monitoring data has been reviewed.
- Revalidation has occurred or is scheduled.
- Incidents during the term have been reviewed and closed.
- The disclosure questionnaire has been refreshed.
- Incorporated terms have been re-reviewed for unilateral change.
- Terms not obtained initially have been re-raised.
- The business case has been re-tested against measured benefit.
- The renewal decision is recorded in the governance decision log.
10
GoHealthcare AI Governance Center
GoHealthcare Clinical Insights
What GoHealthcare observes about artificial intelligence procurement in musculoskeletal specialty organizations.
Restricting Feature Activation Rights Is the Highest-Leverage Free Control
Most artificial intelligence enters a specialty practice through an administrative toggle in a product the organization already owns. Restricting who may operate those toggles, and routing activation through governance, closes the largest bypass in the environment at zero cost. Organizations that implement this typically prevent several ungoverned deployments in the following quarter.
The Recurring Vendor Questionnaire Doubles the Known Inventory
A short written questionnaire sent to every technology vendor reliably surfaces artificial intelligence the organization did not know it had, and continues to surface additions on each cycle. It is more effective than any technical discovery approach because embedded features are a contractual fact before they are a technical one.
Notice of Material Model Change Is the Term That Matters Most
Its absence is what allows validation to be invalidated silently. Vendors resist it less than organizations expect, particularly where the organization offers to accept a reasonable definition of material and a reasonable notice period. Where the vendor will not commit, pair the refusal with quarterly agreement checking against a fixed reference set.
Vendors Frequently Cannot Answer the Input Variable Question
Sometimes because the answer is proprietary, sometimes because the salesperson does not know, and sometimes because the product incorporates a third-party model whose inputs the vendor does not fully control. Record the inability as a material diligence finding, escalate it to the renewal position, and assess whether the organization can discharge its nondiscrimination obligations without it.
Readiness Assessment Belongs Before Signature, Not Before Go-Live
Organizations routinely sign and then discover during implementation that the data the tool requires is held in a system it cannot access, or that the workflow the tool assumes does not exist. By then the money is committed and the assessment becomes a remediation exercise rather than a decision input.
Aggregation Produces Materially Better Terms
Independent practice associations, management services organizations, and group purchasing arrangements obtain artificial intelligence terms that individual specialty practices generally cannot. Where an organization participates in such a structure, raising artificial intelligence terms at that level is more productive than negotiating alone.
Back to page navigation11
GoHealthcare AI Governance Center
GoHealthcare Leadership Perspective
Procurement is where artificial intelligence governance is either enabled or foreclosed. An organization that signs without notice of model changes will spend the term unable to know when its validation became stale. An organization that signs without a clear training data position will spend the term unable to answer a straightforward question from a patient, a payer, or counsel. These are not theoretical exposures; they are the specific gaps GoHealthcare encounters most often, and they are all closeable at signature and largely unclosable afterward.
The executive decision that matters most is a small one: restrict who may enable vendor artificial intelligence features. This costs nothing, requires no negotiation, and closes the path through which most artificial intelligence actually enters the organization. Executives who take only one action from this page should take that one.
The second executive decision is to require the artificial intelligence terms conversation at renewal rather than allowing automatic renewal. Renewal is the organization's only recurring leverage, and it is routinely surrendered by inattention. Calendaring the conversation ninety days before the notice window converts a passive event into an active one and costs a meeting.
Executives should also be prepared to accept a refusal on the record. A vendor that will not commit to notice of material model changes, will not state whether organizational data trains its models, or will not say where processing occurs has provided material information about the risk of the relationship. Recording the refusal in the risk assessment and the governance decision log is a legitimate outcome. Conceding quietly, and leaving the governance body unaware that the control it assumed exists does not, is not.
Finally, there is a categorical line that should be stated as an organizational position rather than negotiated deployment by deployment. No contract term, configuration default, or service design may prevent the organization from meeting a legally required human determination or from preserving clinical primacy. This is not a commercial term and should not be traded against price, functionality, or timeline.
Back to page navigation12
GoHealthcare AI Governance Center
GoHealthcare Prior Authorization Insight
Contract for Encoded Policy Currency
Any authorization support tool that encodes coverage criteria, medical policy versions, or code sets carries currency risk concentrated in a single service line. Establish contractually how the vendor updates encoded policy, how quickly, how the organization is notified, and what happens to in-flight determinations when a policy changes. This is rarely addressed and is a frequent source of systematic error.
Require the Submission Record
For tools that assemble or submit authorization packets, require that the organization can retrieve the packet exactly as submitted, including any generated narrative. Without this, scope determination is impossible when an assertion problem is identified, and the organization cannot reconstruct what a payer actually received.
Understand Clearinghouse Scoring and Suppression
Clearinghouse denial risk scoring frequently includes claim suppression for internal review that the practice is not notified of. Establish contractually what the scoring does, whether claims are held or suppressed, on what basis, and how the practice is notified. Many practices discover this only during
governance discovery.
Do Not Accept Terms That Constrain Appeal or Peer to Peer Practice
Some authorization support arrangements are structured around efficiency metrics that implicitly discourage appeal volume. Where the organization's position is that every clinically indicated denied service is appealed, confirm that no contractual incentive or service design cuts against it.
Back to page navigation13
GoHealthcare AI Governance Center
GoHealthcare Case Study
Fictional Composite
The following case study is an original educational composite created for instructional purposes. It does not describe any actual patient, practice, health system, payer, vendor, or employee. Any resemblance to an actual person or organization is coincidental.
Case Study: The Feature Nobody Bought
Organizational Scenario
A twenty-six provider orthopedic group has used the same practice management and clearinghouse platform for nine years. The current agreement was executed six years ago and incorporates the vendor's online terms by reference. During artificial intelligence governance discovery, the group sends its first written artificial intelligence disclosure questionnaire to the vendor.
Documentation and Structural Challenges
- The vendor's written response identifies four artificial intelligence components in the platform. The group knew about none of them.
- A denial risk scoring model has been applied to all claims for approximately three years and holds a subset for internal review before submission, which delays those claims by one to three days.
- A no-show prediction model has been enabled since a platform update roughly two years earlier.
- An eligibility and benefit inference component fills gaps in payer responses using a model rather than reporting the gap.
- A recently added coding suggestion component is described as available and not currently enabled for this customer.
- The incorporated online terms had been amended four times during the term. The current version includes a broad license to use customer data for product improvement.
- No notice of any of these had been provided in a form the group recognized as notice.
Prior Authorization and Revenue Cycle Barriers
The claim suppression finding is material. The group had attributed a persistent pattern of delayed remittance on a subset of claims to payer behavior. Analysis shows the delay correlates with the vendor's internal hold rather than with payer processing. Separately, the eligibility inference component had, on an unknown number of occasions, reported authorization not required where the payer response was ambiguous.
Payer and Regulatory Considerations
- The broad product improvement license plausibly covers model training on the group's data, which the group had never considered or approved.
- The vendor could not immediately state where processing occurred for two of the four components, one of which involved a subcontracted model provider.
- The eligibility inference behavior created a risk of services delivered without required authorization, which the group needed to scope.
- The group operates in a state participating in the federal Medicare prior authorization model, making the eligibility inference finding more consequential for the affected service lines.
Operational Workflow Response
- All four components are entered in the inventory with named owners and tiered. Denial risk scoring with suppression and eligibility inference are tiered 3. No-show prediction is tiered 2. The unenabled coding component is recorded as available and not enabled, with activation restricted.
- The eligibility inference component is disabled pending assessment, using the group's suspension authority, and the vendor is asked in writing to confirm the behavior and its history.
- The scope of possible services delivered without required authorization is determined with compliance and counsel.
- The claim suppression behavior is analyzed against the remittance pattern and quantified.
- The renewal date, eleven months out, is calendared with an artificial intelligence terms conversation ninety days before the notice window.
- A standard artificial intelligence addendum is drafted with counsel covering notice of material model changes, training data opt-out, processing location disclosure, notice of new and default-enabled features, suppression transparency, and certified deletion.
- Administrative rights to enable vendor features are restricted to two named individuals.
Resolution Strategy
The group does not change platforms. It converts an unknown, ungoverned, contractually unaddressed situation into a known, tiered, owned one, and positions the artificial intelligence terms conversation for the point at which it has leverage.
Outcome
- The eligibility inference component was reconfigured by the vendor to report ambiguity rather than infer, following the group's written escalation.
- The claim suppression analysis quantified a working capital effect the group had not previously attributed correctly, which made the artificial intelligence terms conversation a finance priority rather than a compliance one.
- At renewal the vendor accepted the majority of the addendum, including notice of material model changes, a training data opt-out, processing location disclosure, and notice of new and default-enabled features. It declined broad audit rights.
- The declined audit rights were recorded in the risk assessment, and the group instituted quarterly agreement checking against a fixed reference set as the compensating control.
- The restricted activation rights prevented the coding suggestion component from being enabled during the interim period, which had been proposed by a site manager.
- The group added the artificial intelligence questionnaire to its standard annual vendor review for all technology vendors.
Lessons Learned
- The first artificial intelligence disclosure questionnaire to a long-standing vendor reliably produces surprises.
- Incorporated online terms amended unilaterally during a term are a material and frequently overlooked exposure.
- Behavior attributed to payers should be tested against vendor behavior before being accepted as payer behavior.
- Framing the artificial intelligence terms conversation in financial terms moves it from a compliance request to a business priority.
- A declined term paired with a documented compensating control is a legitimate governance outcome; a declined term concealed from the governance body is not.
- Restricting activation rights pays for itself in prevented deployments within a single quarter.
14
GoHealthcare AI Governance Center
GoHealthcare Best Practices
| Practice | What Good Looks Like |
|---|---|
| Restrict who may enable vendor artificial intelligence features | Named individuals only, with activation routed through the governance body. Free, and closes the largest bypass. |
| Send a recurring written artificial intelligence disclosure questionnaire | To every technology vendor at onboarding, annually, and at each renewal. Retain the answers. |
| Complete readiness assessment before signature | Not before go-live. After signature the assessment becomes remediation. |
| Treat notice of material model changes as non-negotiable | Its absence means validation can be invalidated silently with no signal. |
| Establish the training data position and processing location in writing | For every vendor, at every tier, including subcontractor processing. |
| Use a standard artificial intelligence addendum | Short, reasonable, consistently presented. Accepted far more often than ad hoc redlines. |
| Calendar the terms conversation ninety days before the notice window | Renewal is the only recurring leverage and is routinely surrendered by inattention. |
| Record refusals in the risk assessment and decision log | A declined term with a documented compensating control is legitimate. A concealed concession is not. |
| Never trade the categorical constraints | No term may prevent a legally required human determination or clinical primacy, regardless of price or functionality. |
| Aggregate where the structure exists | Independent practice associations, management services organizations, and group purchasing obtain materially better terms. |
15
GoHealthcare AI Governance Center
What are the common mistakes?
Original section: Common Mistakes
| Mistake | Why It Fails | Correction |
|---|---|---|
| Allowing any administrator to enable vendor artificial intelligence features | Most artificial intelligence enters through this path, entirely ungoverned. | Restrict activation rights to named individuals and route through governance. |
| Assuming a pre-existing business associate agreement covers the feature | Agreements signed before the feature existed are typically silent on model training and processing location. | Reopen the agreement at readiness assessment or renewal with a specific artificial intelligence addendum. |
| Ignoring incorporated online terms | They are frequently amended unilaterally during the term and may include a broad data license. | Review incorporated terms at each renewal and seek notice plus a termination right on material change. |
| Signing before readiness assessment | Data access and workflow gaps surface during implementation when money is already committed. | Complete readiness assessment before signature. |
| Accepting vendor performance claims as validation | Performance was measured in the vendor's population, not the organization's. | Require a local validation plan agreed before signature. |
| Conceding notice of material model changes | The organization loses any signal that validation has gone stale. | Treat as non-negotiable, and where refused, add quarterly agreement checking as a compensating control. |
| Treating the input variable question as answered when it was evaded | The organization cannot discharge nondiscrimination obligations without it. | Record the inability as a material finding and escalate to the renewal position. |
| Allowing automatic renewal to pass | Surrenders the organization's only recurring leverage. | Calendar the terms conversation ninety days before the notice window. |
| Applying procurement policy only above a dollar threshold | Artificial intelligence risk does not scale with price, and free tools are common. | Apply artificial intelligence procurement policy regardless of cost. |
| Negotiating term by term with ad hoc redlines | Slow, inconsistent, and less likely to be accepted. | Use a standard short addendum presented consistently. |
16
GoHealthcare AI Governance Center
What are the most important implementation pearls and pitfalls?
Original section: Pearls and Pitfalls
Pearls
- Restricting vendor feature activation rights is the highest-leverage free control in the entire governance program.
- The first artificial intelligence disclosure questionnaire to a long-standing vendor reliably produces surprises, and the practice keeps producing them on each cycle.
- Framing artificial intelligence terms in financial rather than compliance language moves the conversation from a request to a business priority.
- A standard short addendum is accepted far more often than equivalent ad hoc redlines.
- A declined term paired with a documented compensating control is a legitimate and defensible governance outcome.
- Behavior attributed to payers should be tested against vendor behavior first; clearinghouse suppression is frequently the actual cause.
- Aggregating through an association or management services organization produces terms an individual specialty practice cannot obtain.
Pitfalls
- Terms incorporated by reference can be amended unilaterally during a term and are rarely re-read.
- A broad product improvement data license frequently covers model training even where the business associate agreement appears restrictive.
- Limitation of liability clauses that exclude artificial intelligence output shift the entire risk of the output to the party that does not control the model.
- Vendor discretion to define material change renders a change notice commitment unenforceable in practice.
- Data deletion subject to vendor backup policy frequently means indefinite retention.
- Automatic renewal with short notice windows eliminates the leverage the organization was counting on.
- Free and low-cost tools bypass procurement thresholds while carrying full artificial intelligence risk.
17
GoHealthcare AI Governance Center
What are the most frequently asked questions about artificial intelligence procurement?
Original section: Frequently Asked Questions
The questions below are drawn from the questions GoHealthcare is actually asked by musculoskeletal specialty practices, ambulatory surgery centers, and health system service lines.
Q1. Where does most artificial intelligence actually enter our organization?
As an embedded feature in a product already owned, enabled by an administrative toggle, governed by terms incorporated by reference into an agreement that predates the feature. Very little arrives through a procurement process, which is why detection precedes negotiation.
Q2. What is the single most effective procurement control?
Restricting who may enable vendor artificial intelligence features and routing activation through the governance body. It costs nothing, requires no negotiation, and closes the largest bypass in the environment.
Q3. What should the vendor questionnaire ask?
Whether the product contains predictive or generative components; whether any are enabled by default; whether any were enabled for this customer and when; whether customer data is used to train, tune, or improve models; where processing occurs including subcontractors; and whether the vendor will provide written notice of material model changes.
Q4. Which contract terms are truly non-negotiable?
A business associate agreement covering the artificial intelligence processing with flow-down; written notice of material model changes; a stated training data position with an opt-out or negotiated permission; disclosure of processing location; data return and certified deletion at termination; an immediate suspension right; and no term that would prevent a legally required human determination or clinical primacy.
Q5. What do we do if the vendor will not agree to a non-negotiable term?
Escalate to the governance body and counsel rather than conceding quietly. The options are to decline the acquisition, to accept with a documented compensating control, or to defer to renewal. What is not acceptable is a concession the governance body is unaware of, because the body will continue assuming a control exists.
Q6. What is a reasonable compensating control for the absence of model change notice?
Quarterly agreement checking against a small fixed reference set of representative cases. A behavior change produces a detectable signal without relying on vendor notice. This is inexpensive and should arguably be run even where notice is contractually required.
Q7. How much diligence is proportionate?
By tier. Tier 1 requires the questionnaire, the business associate agreement check, processing location, and training data position. Tier 3 adds performance evidence, input variables, source attributes, device status where applicable, change management, reference checks, an agreed local validation plan, and audit rights.
Q8. The vendor cannot tell us what input variables the model uses. Now what?
Record it as a material diligence finding, escalate it to the renewal position, and assess with compliance and counsel whether the organization can discharge its nondiscrimination obligations for this deployment without the information. For some tier 3 deployments the honest answer is that it cannot.
Q9. Should readiness assessment happen before or after signature?
Before signature. After signature, the assessment becomes a remediation exercise conducted with the money already committed, and the organization loses the ability to decline.
Q10. Does a business associate agreement resolve the training data question?
Not reliably. Business associate agreements address permitted uses of protected health information, but a separate broad license to use customer data for product improvement frequently appears elsewhere in the agreement or in incorporated terms. Read specifically for the training question rather than assuming.
Q11. Do we have any leverage with a large vendor?
More than most specialty organizations assume, and it is concentrated at renewal. Time the conversation, present a short standard addendum rather than ad hoc redlines, separate disclosure requests from negotiated terms, and aggregate through any association or management services structure available.
Q12. Should procurement policy apply to free tools?
Yes. Artificial intelligence risk does not scale with price. A free generative tool used to draft clinical communication carries more risk than most paid administrative systems. Apply the policy regardless of cost.
Q13. What should we do about incorporated online terms?
Review them at each renewal, note whether they were amended during the term, and seek notice of material change plus a right to terminate. A vendor's unilateral right to amend artificial intelligence terms is itself a diligence finding worth recording.
Q14. How do we handle indemnification for artificial intelligence output?
Seek it, coordinate it with the organization's insurance position, and scrutinize any limitation of liability that excludes artificial intelligence output, which would shift the entire risk to the party that does not
control the model. This is a counsel and broker conversation, not an administrative one.
Q15. What about tools that may be regulated as devices?
Confirm clearance status, the cleared intended use, and any predetermined change control plan, and confirm that the organization's intended use falls within the cleared indication. A predetermined change control plan means the vendor may modify the model within a pre-authorized scope, which the organization should understand before signing.
Q16. How often should we re-run the vendor questionnaire?
At onboarding, annually, and at each renewal. Vendors add and enable components continuously, and the questionnaire is the practical detection mechanism where contractual notice is absent.
Q17. Should renewal of a tier 3 system be a governance decision?
Yes. Require current monitoring data, a revalidation within the term, closure of any incidents, a refreshed questionnaire, a re-review of incorporated terms, and a business case re-tested against measured benefit rather than the original projection.
Q18. What if we discover a component that has been running for years?
Inventory it, assign an owner, tier it, assess it, and where the finding has compliance implications, scope the historical exposure with compliance and counsel. Do not treat length of operation as evidence of safety; treat it as a scope question.
Q19. Can we require the vendor to tell us where processing occurs?
Ask in writing at minimum, and seek it contractually. At least one state directly restricts offshoring of electronic medical records, so the organization cannot assess its own compliance without the answer, including for subcontracted model providers in the chain.
Q20. How does procurement relate to the voluntary artificial intelligence certification?
Substantially. Effective data management and transparency expectations are discharged largely through what the organization secured contractually. An organization with strong artificial intelligence contract terms and a documented diligence practice has built much of the evidence for two of the five certification areas.
Back to page navigation18
GoHealthcare AI Governance Center
What are the key takeaways for healthcare leaders?
Original section: Key Takeaways
- Procurement is the point of maximum leverage. Terms not obtained at signature become controls the organization cannot exercise for the term.
- Most artificial intelligence enters a specialty organization as an embedded vendor feature, not through procurement. Detection precedes negotiation.
- Restricting who may enable vendor artificial intelligence features is the highest-leverage free control in the entire governance program.
- A recurring written vendor disclosure questionnaire reliably doubles the known inventory and keeps producing findings.
- Written notice of material model changes is the term that matters most; without it, validation can be invalidated silently.
- Readiness assessment belongs before signature, not before go-live.
- Renewal is the only recurring leverage and is routinely surrendered by inattention. Calendar the terms conversation ninety days ahead.
- No term may prevent a legally required human determination or clinical primacy. That constraint is categorical and is not traded against price.
19
GoHealthcare AI Governance Center
What should healthcare leaders monitor next in artificial intelligence governance?
Original section: Future Outlook
Standard Artificial Intelligence Contract Terms Are Emerging
Health system consortia, group purchasing organizations, and professional associations are converging on common artificial intelligence contract language covering change notice, training data, transparency, and audit. Specialty organizations should adopt emerging standard language rather than drafting independently, because standard language is accepted more readily and because divergence weakens the collective position.
Transparency Obligations Will Shift Toward Vendors
Source attribute requirements in certified health information technology and transparency expectations in voluntary certification are gradually moving the burden of disclosure toward developers. Organizations should ask for more, not less, and should treat current refusals as likely to become untenable over the next contract cycle.
Foundation Model Supply Chains Will Complicate Diligence
As more clinical and operational products are built on general purpose models supplied by third parties, the questions of who controls the model, who may change it, where processing occurs, and who is accountable for output become multi-party questions. Contract terms should require disclosure of and flow-down to the model provider in the chain.
Artificial Intelligence Terms Will Enter Payer and Partner Diligence
Delegated arrangements, value-based contracts, and health system affiliations are beginning to inquire into how a practice's artificial intelligence vendors are contracted. Organizations with a documented diligence practice and a standard addendum will find these requests routine.
Back to page navigation20
GoHealthcare AI Governance Center
Which authoritative sources support this guidance?
Original section: References
- Office for Civil Rights, Department of Health and Human Services. Business associate guidance. Website: https://www.hhs.gov/hipaa
- Food and Drug Administration. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions. Website: https://www.fda.gov
- Centers for Medicare and Medicaid Services. Wasteful and Inappropriate Service Reduction (WISeR) Model. Website: https://www.cms.gov/priorities/innovation/innovation-models/wiser
- Centers for Medicare and Medicaid Services. WISeR Model Provider and Supplier Operational Guide. Website: https://www.cms.gov/priorities/innovation/files/wiser-provider-supplier-guide.pdf
- Centers for Medicare and Medicaid Services. Health Technology Ecosystem initiative. Website: https://www.cms.gov/initiatives/health-technology-ecosystem/overview
- Department of Health and Human Services, Office for Civil Rights. Nondiscrimination in Health Programs and Activities, final rule, 89 Federal Register 37522, May 6, 2024. Website: https://www.federalregister.gov/documents/2024/05/06/2024-08711/nondiscrimination-in-health-programs-and-activities
- Electronic Code of Federal Regulations. 45 CFR 92.210, Nondiscrimination in the use of patient care decision support tools. Website: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-92/subpart-C/section-92.210
- Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology. Decision Support Interventions certification criterion, 45 CFR 170.315(b)(11), test method. Website: https://healthit.gov/test-method/decision-support-interventions/
- Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology. HTI-1 Decision Support Interventions fact sheet. Website: https://www.healthit.gov/sites/default/files/page/2023-12/HTI-1_DSI_fact%20sheet_508.pdf
- Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology. Health IT Certification Program Resource Guide, Decision Support Interventions criterion. Website: https://healthit.gov/wp-content/uploads/2024/05/DSI-Criterion-Resource-Guide_508.pdf
- Food and Drug Administration. Artificial Intelligence in Software as a Medical Device. Website: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-software-medical-device
- Food and Drug Administration. Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations, draft guidance, January 6, 2025. Website: https://www.fda.gov/media/184856/download
- National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework. Website: https://www.nist.gov/itl/ai-risk-management-framework
- Joint Commission. Responsible Use of AI in Healthcare certification. Website: https://www.jointcommission.org/en-us/certification/responsible-use-of-ai-in-healthcare
- Joint Commission and Coalition for Health AI. Guidance on Responsible Use of AI in Healthcare, September 17, 2025. Website: https://www.jointcommission.org/en-us/knowledge-library/news/2025-09-jc-and-chai-release-initial-guid ance-to-support-responsible-ai-adoption
- Coalition for Health AI. Website: https://www.chai.org
- Colorado General Assembly. Senate Bill 24-205, Consumer Protections for Artificial Intelligence. Website: https://leg.colorado.gov/bills/sb24-205
- Texas Legislature Online. House Bill 149, Texas Responsible Artificial Intelligence Governance Act. Website: https://capitol.texas.gov
- Congressional Research Service. Overview of the Medicare Wasteful and Inappropriate Service Reduction (WISeR) Model, IF13133. Website: https://www.congress.gov/crs-product/IF13133
- American Medical Association. Augmented intelligence in medicine. Website: https://www.ama-assn.org/practice-management/digital-health/augmented-intelligence-medicine
- American Medical Association. State legislative update on artificial intelligence in health care. Website: https://www.ama-assn.org/system/files/issue-brief-state-legislative-update-ai-health-care.pdf
- International Organization for Standardization. ISO/IEC 42001 artificial intelligence management system. Website: https://www.iso.org/standard/42001
21
GoHealthcare AI Governance Center
Reading Recommendations
The sources below are recommended for readers who need to go deeper than this page. Only authoritative primary sources, standards bodies, accrediting organizations, professional societies, and peer-reviewed literature are listed.
1. Assistant Secretary for Technology Policy. Health IT Certification Program Resource Guide, Decision Support Interventions criterion, for the source attributes a vendor should be able to supply. Website: https://www.healthit.gov
2. Food and Drug Administration. Artificial Intelligence in Software as a Medical Device, including predetermined change control plan guidance. Website: https://www.fda.gov
3. Joint Commission and Coalition for Health AI. Guidance on Responsible Use of AI in Healthcare, on data management and transparency. Website: https://www.jointcommission.org
4. International Organization for Standardization. ISO/IEC 42001, supplier and third-party clauses. Website: https://www.iso.org/standard/42001
Back to page navigation22
GoHealthcare AI Governance Center
How are the twelve AI governance domains connected?
Original section: AI Governance Center Navigation Index
The GoHealthcare AI Governance Center is a thirteen page set. The hub landing page and twelve topic pages are written to be read independently, and each is self-contained. Where a topic is developed in depth on another page, this document points to that page rather than duplicating the material. The page currently open is marked.
| Identifier | Page | Coverage |
|---|---|---|
| GH-MSK-AI-000 | AI Governance Center | Hub landing page, series map, and how to use the Center |
| GH-MSK-AI-001 | AI Governance | Governance structure, charter, decision rights, and accountability |
| GH-MSK-AI-002 | AI Readiness | Data, workflow, workforce, and infrastructure readiness assessment |
| GH-MSK-AI-003 | AI Policies | The policy stack an MSK organization needs and what each policy says |
| GH-MSK-AI-004 | AI Risk Management | Risk taxonomy, tiering, assessment, controls, and monitoring |
| GH-MSK-AI-005 | AI Ethics | Ethical principles applied to MSK operational and clinical use |
| GH-MSK-AI-006 | AI Oversight | Human oversight, performance monitoring, audit, and escalation |
| GH-MSK-AI-007 | AI Procurement [ THIS PAGE ] | Vendor evaluation, diligence, contracting, and contract terms |
| GH-MSK-AI-008 | AI Use Cases | Prioritized MSK specialty use cases with risk tier and evidence needs |
| GH-MSK-AI-009 | AI Implementation | Pilot design, validation, go-live, change control, and scaling |
| GH-MSK-AI-010 | AI Templates | Reusable governance document templates and drafting instructions |
| GH-MSK-AI-011 | AI Checklists | Operational checklists across the full artificial intelligence lifecycle |
| GH-MSK-AI-012 | AI Resources | Authoritative primary sources, standards, and monitoring calendar |
Publication note. Child pages of the AI Governance Center are published to reserved Knowledge Center slugs. Until each page is live, internal cross references are rendered as plain text rather than active links, consistent with GoHealthcare library practice of never activating a link to an unpublished page.
Back to page navigation23
GoHealthcare AI Governance Center
Related GoHealthcare Resources
The following GoHealthcare Knowledge Center resources are the closest operational companions to this page. Links become active as each page is published.
| Identifier | Resource | Relationship |
|---|---|---|
| GH-MSK-AI-000 | AI Governance Center | Hub landing page, series map, and how to use the Center |
| GH-MSK-AI-001 | AI Governance | Governance structure, charter, decision rights, and accountability |
| GH-MSK-AI-002 | AI Readiness | Data, workflow, workforce, and infrastructure readiness assessment |
| GH-MSK-AI-003 | AI Policies | The policy stack an MSK organization needs and what each policy says |
| GH-MSK-AI-004 | AI Risk Management | Risk taxonomy, tiering, assessment, controls, and monitoring |
| GH-MSK-AI-005 | AI Ethics | Ethical principles applied to MSK operational and clinical use |
| GH-MSK-AI-006 | AI Oversight | Human oversight, performance monitoring, audit, and escalation |
| GH-MSK-AI-008 | AI Use Cases | Prioritized MSK specialty use cases with risk tier and evidence needs |
| GH-MSK-AI-009 | AI Implementation | Pilot design, validation, go-live, change control, and scaling |
| GH-MSK-AI-010 | AI Templates | Reusable governance document templates and drafting instructions |
| GH-MSK-AI-011 | AI Checklists | Operational checklists across the full artificial intelligence lifecycle |
| GH-MSK-AI-012 | AI Resources | Authoritative primary sources, standards, and monitoring calendar |
Companion Series Outside the AI Governance Center
| Series | Coverage |
|---|---|
| GoHealthcare Compliance Center | Twelve guide compliance series covering documentation integrity, auditing, and regulatory risk. |
| Prior Authorization Specialty Hub | Thirteen page hub covering musculoskeletal prior authorization operations end to end. |
| Revenue Cycle Knowledge Center | Reimbursement methodology, denial analytics, and revenue integrity. |
| Ambulatory Surgery Center Specialty Hub | Eighteen document set including state regulatory profiles for all fifty states and the District of Columbia. |
| CMS Ambulatory Specialty Model Guide | Operational guide to the mandatory specialty model beginning January 1, 2027 for physical medicine and rehabilitation and the low back pain cohort. |
24
GoHealthcare AI Governance Center
Recommended Downloads and Visual Recommendations
Recommended Downloads
- Vendor Artificial Intelligence Disclosure Questionnaire.
- Artificial Intelligence Contract Addendum Template, counsel-reviewable.
- Diligence Requirements Matrix by risk tier.
- Non-Negotiable and Desirable Terms Checklist.
- Terms to Scrutinize Review Guide.
- Tier 3 Renewal Decision Package Template.
- Vendor Feature Activation Rights Restriction Procedure.
Visual Recommendations
- Artificial intelligence entry path diagram showing the six ways capability enters without procurement.
- Diligence requirements matrix rendered as a tier-by-item grid.
- Contract term priority pyramid separating non-negotiable, desirable, and scrutinize categories.
- Negotiating leverage timeline showing the renewal window.
- Vendor questionnaire cycle diagram.
- Renewal decision gate flowchart.
25
GoHealthcare AI Governance Center
Pre-Publication Quality Assurance Sign-Off
This document is released subject to the five standing GoHealthcare pre-publication gates. Each gate is confirmed by the responsible reviewer before external publication. Gates that remain open are recorded here rather than omitted.
| Gate | Reviewer of Record | Status |
|---|---|---|
| 1. Clinical and medical reviewer sign-off | Designated clinical reviewer | Open |
| 2. Payer policy currency confirmation | Payer policy analyst | Open |
| 3. WISeR Model status confirmation | Regulatory analyst | Open |
| 4. Legal and counsel review | Retained healthcare counsel | Open |
| 5. Brand and accessibility review | Brand and accessibility reviewer | Open |
Note on gate 5. Confirmed brand hexadecimal codes and logo files have not yet been delivered. The accent color used throughout the AI Governance Center was sampled directly from the client-supplied AI Governance Center graphic. A single-line palette swap is staged in the publishing engine for the moment final brand values are issued.
Back to page navigation26
GoHealthcare AI Governance Center
How is this guidance versioned and maintained?
Original section: Document History
| Version | Date | Change Summary | Approved By |
|---|---|---|---|
| 1.0 | August 6, 2026 | Initial publication. | Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions |
Material corrections are logged in this table with a version increment rather than a silent edit. Where a correction identified in this document affects another title in the GoHealthcare MSK Specialty Procedure Library, the correction is propagated across affected titles at the time it is logged.
Back to page navigation27
GoHealthcare AI Governance Center
Educational Disclaimer
1. Purpose and Nature of This Document
This document is published by GoHealthcare Practice Solutions as part of the GoHealthcare MSK Specialty Procedure Library and its AI Governance Center. It is intended solely for educational and operational reference purposes for healthcare professionals, practice administrators, utilization management teams, revenue cycle professionals, compliance officers, and healthcare executives. It is not a clinical textbook, a procedural technique manual, a legal opinion, a regulatory filing, or a certification program.
2. No Medical Advice and No Physician Training
Nothing in this document constitutes medical advice or establishes a standard of clinical care. This document does not provide procedural technique instruction, surgical technique instruction, needle placement instruction, medication dosing, or imaging guidance instruction, and it must not be used for those purposes. All clinical decisions remain the exclusive responsibility of the treating licensed practitioner exercising independent professional judgment with respect to the individual patient.
3. No Legal Advice and No Attorney-Client Relationship
Artificial intelligence law, health information privacy law, nondiscrimination law, corporate practice of medicine doctrine, and insurance regulation vary by jurisdiction and change frequently. Nothing in this document constitutes legal advice, and no attorney-client relationship is created by reading or relying upon it. Organizations must obtain advice from qualified counsel licensed in the applicable jurisdiction before adopting policies, executing vendor agreements, or making regulatory determinations.
4. No Guarantee of Coverage, Payment, or Approval
Coverage positions, prior authorization requirements, utilization management vendor criteria, and payment policies described in this document are summaries prepared for educational purposes. They do not guarantee coverage, prior authorization approval, or payment for any item or service. Benefit determinations depend upon the individual member benefit plan, the applicable contract, the jurisdiction, the date of service, and the clinical documentation submitted.
5. Verification Against Primary Sources Is Required
Every regulatory citation, coverage position, and policy reference in this document was verified against a primary source as of the effective date shown on the cover. Regulations, sub-regulatory guidance, executive orders, litigation outcomes, certification standards, and payer medical policies are subject to change without notice, and several artificial intelligence requirements described here are the subject of active litigation or pending amendment. The reader is responsible for verifying current requirements directly with the issuing authority before acting.
6. Artificial Intelligence Specific Limitations
This document describes governance practices for artificial intelligence used in healthcare operations. It does not validate, certify, endorse, or assess the safety, accuracy, fairness, or regulatory status of any specific artificial intelligence product, model, vendor, or deployment. Organizations remain solely responsible for the selection, validation, monitoring, and use of any artificial intelligence tool, and for the outputs that tool produces within their environment.
7. Human Accountability Is Not Delegable
Nothing in this document supports or authorizes the substitution of artificial intelligence for licensed clinical judgment, for the physician review required in utilization management determinations, or for the professional responsibility of any licensed or otherwise qualified individual. Where federal or state law requires that a qualified human make or own a determination, that requirement is not satisfied by an automated output, regardless of the confidence, accuracy, or sophistication of the system that produced it.
8. Coding and Billing Scope Limitation
Where coding concepts appear in this document, they are presented at an operational and documentation level only. This document does not provide fee schedule amounts, relative value unit values, National Correct Coding Initiative edit tables, Medically Unlikely Edit values, or reimbursement methodology analysis. Current Procedural Terminology is a registered trademark of the American Medical Association. All code sets remain the property of their respective owners and must be licensed and applied from official sources.
9. Authorship and Attribution
This document was developed and published by GoHealthcare Practice Solutions, under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions. GoHealthcare Practice Solutions is a national Musculoskeletal Specialty Management Services Organization supporting Pain Management, Orthopedic Surgery, Spine Surgery, Neurosurgery, Neuromodulation, Ambulatory Surgery Centers, Sports Medicine, Physical Medicine and Rehabilitation, Podiatry, Rheumatology, and Workers' Compensation.
10. Third Party Content and Trademarks
Payer policy content, utilization management vendor criteria, accreditation standards, and consensus framework material referenced in this document have been synthesized into original language and are not reproduced verbatim. All trademarks, service marks, and policy documents referenced remain the property of their respective owners. Reference to any organization, framework, standard, or product does not imply affiliation, sponsorship, or endorsement in either direction.
11. Case Studies Are Fictional Composites
Any case study appearing in this document is an original educational composite created for instructional purposes. It does not describe any actual patient, practice, health system, payer, vendor, or employee. Any resemblance to an actual person or organization is coincidental and unintended.
12. Privacy and Protected Health Information
This document contains no protected health information. Organizations applying the practices described here remain fully responsible for compliance with the Health Insurance Portability and Accountability Act, the Health Information Technology for Economic and Clinical Health Act, state health privacy law, state consumer privacy law, and all applicable business associate and vendor contract obligations, including obligations that attach when protected health information is disclosed to an artificial intelligence vendor or processed by an artificial intelligence system.
13. No Warranty and Limitation of Liability
This document is provided on an as-is basis without warranty of any kind, whether express or implied, including any implied warranty of accuracy, completeness, merchantability, or fitness for a particular purpose. To the fullest extent permitted by law, GoHealthcare Practice Solutions and its officers, employees, and contributors disclaim liability for any loss, claim, penalty, denial, delay, or damage arising from the use of, or reliance upon, this document.
14. Permitted Use and Redistribution
This document may be used internally by healthcare organizations for education, training, policy development, and operational reference. It may not be resold, rebranded, altered, or redistributed as the work of another party. Attribution to GoHealthcare Practice Solutions and to Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions, must be retained in any permitted internal reproduction.
15. Currency, Feedback, and Document Control
Readers who identify an error, an outdated citation, or a superseded requirement are encouraged to report it so that a correction can be logged in the Document History and propagated across affected titles in the library. Material corrections are published with a version increment rather than a silent edit. Contact GoHealthcare Practice Solutions through https://www.gohealthcarellc.com.
Summary
GH-MSK-AI-007, Version 1.0. This document is intended for educational and operational reference purposes only. It does not replace physician clinical judgment, payer policy review, legal advice, or official guidance from the Centers for Medicare and Medicaid Services. Coverage policies, artificial intelligence requirements, coding guidance, and reimbursement requirements should always be verified with the applicable payer, regulator, and current regulatory sources.
Developed and published by GoHealthcare Practice Solutions, under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions.
Website: https://www.gohealthcarellc.com
Back to page navigationWhat should you read next in the AI Governance Center?
These related domains extend the same governance framework and should be used together rather than as standalone controls.
Artificial Intelligence ReadinessAssess data, workflow, workforce, infrastructure, privacy, security, and operational readiness before deploying artificial intelligence in musculoskeletal specialty healthcare.Artificial Intelligence Risk ManagementA four-tier healthcare AI risk management framework covering risk taxonomy, assessment, fairness, controls, thresholds, monitoring, revalidation, and residual risk acceptance.Artificial Intelligence ImplementationAn eight-phase healthcare AI implementation method covering preparation, pilot design, local validation, governance decision, go-live, stabilization, scaling, change control, and retirement.Artificial Intelligence TemplatesReusable healthcare AI governance document templates and drafting instructions for charters, policies, system records, risk assessments, vendor diligence, monitoring, incidents, and audit evidence.
Build a Defensible Healthcare AI Governance Program
GoHealthcare Practice Solutions supports musculoskeletal specialty practices, ambulatory surgery centers, hospitals, and service lines with AI governance, prior authorization, patient access, documentation, revenue cycle, compliance, and operational improvement.
Professional Disclaimer
This material is intended for professional education and operational guidance. It does not replace clinical judgment, official coding publications, payer policies, benefit-plan documents, legal advice, compliance review, or current Centers for Medicare and Medicaid Services guidance. Artificial intelligence law, regulation, accreditation expectations, payer requirements, coverage policies, and technology capabilities change frequently. Verify the live governing source, current effective date, operating jurisdiction, contractual obligations, and patient-specific circumstances before operational reliance.
Nothing in this resource guarantees authorization, coverage, reimbursement, regulatory compliance, certification, a specific clinical outcome, or a specific claim determination. Artificial intelligence must not replace a legally required human determination or physician clinical judgment.
Developed by
GoHealthcare Practice Solutions
Under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions
Credentials: MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare AI Governance
This resource reflects more than three decades of healthcare operations experience across pain management, spine, orthopedics, patient access, prior authorization, revenue cycle management, compliance, workforce operations, and healthcare technology.